361 related articles for article (PubMed ID: 35246764)
1. Changes of gut microbiota in diabetic nephropathy and its effect on the progression of kidney injury.
Cai K; Ma Y; Cai F; Huang X; Xiao L; Zhong C; Ren P; Luo Q; Chen J; Han F
Endocrine; 2022 May; 76(2):294-303. PubMed ID: 35246764
[TBL] [Abstract][Full Text] [Related]
2. The change of gut microbiota-derived short-chain fatty acids in diabetic kidney disease.
Zhong C; Dai Z; Chai L; Wu L; Li J; Guo W; Zhang J; Zhang Q; Xue C; Lin H; Luo Q; Cai K
J Clin Lab Anal; 2021 Dec; 35(12):e24062. PubMed ID: 34689373
[TBL] [Abstract][Full Text] [Related]
3. Sodium butyrate ameliorates diabetic retinopathy in mice via the regulation of gut microbiota and related short-chain fatty acids.
Huang Y; Wang Z; Ye B; Ma JH; Ji S; Sheng W; Ye S; Ou Y; Peng Y; Yang X; Chen J; Tang S
J Transl Med; 2023 Jul; 21(1):451. PubMed ID: 37420234
[TBL] [Abstract][Full Text] [Related]
4. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
[No Abstract] [Full Text] [Related]
5. Butyrate ameliorates skeletal muscle atrophy in diabetic nephropathy by enhancing gut barrier function and FFA2-mediated PI3K/Akt/mTOR signals.
Tang G; Du Y; Guan H; Jia J; Zhu N; Shi Y; Rong S; Yuan W
Br J Pharmacol; 2022 Jan; 179(1):159-178. PubMed ID: 34638162
[TBL] [Abstract][Full Text] [Related]
6. Dietary Fiber Protects against Diabetic Nephropathy through Short-Chain Fatty Acid-Mediated Activation of G Protein-Coupled Receptors GPR43 and GPR109A.
Li YJ; Chen X; Kwan TK; Loh YW; Singer J; Liu Y; Ma J; Tan J; Macia L; Mackay CR; Chadban SJ; Wu H
J Am Soc Nephrol; 2020 Jun; 31(6):1267-1281. PubMed ID: 32358041
[TBL] [Abstract][Full Text] [Related]
7. Empagliflozin ameliorates type 2 diabetes mellitus-related diabetic nephropathy via altering the gut microbiota.
Deng L; Yang Y; Xu G
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Dec; 1867(12):159234. PubMed ID: 36185030
[TBL] [Abstract][Full Text] [Related]
8. The potential role of the gut microbiota in modulating renal function in experimental diabetic nephropathy murine models established in same environment.
Li Y; Su X; Gao Y; Lv C; Gao Z; Liu Y; Wang Y; Li S; Wang Z
Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165764. PubMed ID: 32169506
[TBL] [Abstract][Full Text] [Related]
9. Exogenous spermine attenuates diabetic kidney injury in rats by inhibiting AMPK/mTOR signaling pathway.
Zhang X; Zhang L; Chen Z; Li S; Che B; Wang N; Chen J; Xu C; Wei C
Int J Mol Med; 2021 Mar; 47(3):. PubMed ID: 33537831
[TBL] [Abstract][Full Text] [Related]
10. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli.
Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L
Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469
[TBL] [Abstract][Full Text] [Related]
11. Cyclocarya paliurus triterpenic acids fraction attenuates kidney injury via AMPK-mTOR-regulated autophagy pathway in diabetic rats.
Zhang XX; Jiang CH; Liu Y; Lou DX; Huang YP; Gao M; Zhang J; Yin ZQ; Pan K
Phytomedicine; 2019 Nov; 64():153060. PubMed ID: 31401495
[TBL] [Abstract][Full Text] [Related]
12. [Carnosine protects against diabetic nephropathy in rats by activating the AKT/mTOR pathway and restoring autophagy in the renal tissue].
Ren Y; Lu J; Yu L; Li Z; Wang G; Yang J
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Nov; 43(11):1965-1970. PubMed ID: 38081616
[TBL] [Abstract][Full Text] [Related]
13. Punicalagin alleviates renal injury
Hua Q; Han Y; Zhao H; Zhang H; Yan B; Pei S; He X; Li Y; Meng X; Chen L; Zhong F; Li D
Food Funct; 2022 Jan; 13(2):867-879. PubMed ID: 34989745
[TBL] [Abstract][Full Text] [Related]
14. Inulin-type fructans change the gut microbiota and prevent the development of diabetic nephropathy.
Luo L; Luo J; Cai Y; Fu M; Li W; Shi L; Liu J; Dong R; Xu X; Tu L; Yang Y
Pharmacol Res; 2022 Sep; 183():106367. PubMed ID: 35882293
[TBL] [Abstract][Full Text] [Related]
15. Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition.
Tao S; Li L; Li L; Liu Y; Ren Q; Shi M; Liu J; Jiang J; Ma H; Huang Z; Xia Z; Pan J; Wei T; Wang Y; Li P; Lan T; Tang X; Zeng X; Lei S; Tang H; Ma L; Fu P
Acta Diabetol; 2019 May; 56(5):581-592. PubMed ID: 30888537
[TBL] [Abstract][Full Text] [Related]
16. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
Chen SJ; Chen CC; Liao HY; Lin YT; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
Neurology; 2022 Feb; 98(8):e848-e858. PubMed ID: 34996879
[TBL] [Abstract][Full Text] [Related]
17. Sustained Dysbiosis and Decreased Fecal Short-Chain Fatty Acids after Traumatic Brain Injury and Impact on Neurologic Outcome.
Opeyemi OM; Rogers MB; Firek BA; Janesko-Feldman K; Vagni V; Mullett SJ; Wendell SG; Nelson BP; New LA; Mariño E; Kochanek PM; Bayır H; Clark RSB; Morowitz MJ; Simon DW
J Neurotrauma; 2021 Sep; 38(18):2610-2621. PubMed ID: 33957773
[TBL] [Abstract][Full Text] [Related]
18. Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors.
de la Cuesta-Zuluaga J; Mueller NT; Álvarez-Quintero R; Velásquez-Mejía EP; Sierra JA; Corrales-Agudelo V; Carmona JA; Abad JM; Escobar JS
Nutrients; 2018 Dec; 11(1):. PubMed ID: 30591685
[TBL] [Abstract][Full Text] [Related]
19. Effect of miR-29c on renal fibrosis in diabetic rats via the AMPK/mTOR signaling pathway.
Shao H; Huang Y; Hu HL; Fan WX; Yin XN
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6250-6256. PubMed ID: 31364127
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota dysbiosis-induced activation of the intrarenal renin-angiotensin system is involved in kidney injuries in rat diabetic nephropathy.
Lu CC; Hu ZB; Wang R; Hong ZH; Lu J; Chen PP; Zhang JX; Li XQ; Yuan BY; Huang SJ; Ruan XZ; Liu BC; Ma KL
Acta Pharmacol Sin; 2020 Aug; 41(8):1111-1118. PubMed ID: 32203081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
